Home Daily Stock Opinions and Ratings Novavax Inc (NVAX-Q)

Trending stocks today

Tesla Inc Verizon Communications Starbucks Astrazeneca P L C Brookfield Corp NextEra Energy Alimentation Couche-Tard Black Diamond Group Cheniere Energy Inc PDD Holdings Crescent Point Energy Corp Paramount Resources Precision Drilling Astera Labs Marvell Technology Group Broadcom Invesco QQQ Trust Series 1 Coca-Cola Company Loews Corp

Novavax Inc (NVAX-Q)

NEW AI Investor Insights
33 watching

NASDAQ:NVAX

4.15
0.04 (0.95%) 1d
Apr 24, 2024, 7:59 pm
0

Related posts

Mixed day amid earningsTSX and S&P inch up to new highsTech slides, Dow flat
SELL

Novavax Inc(NVAX-Q)

11/05/2022
Novavax Inc
Historically not a successful vaccine developer. Shares were $258 last November but fallen to $42. This can fall further. He's never liked it.
Pharma & Healthcare
Jim Cramer - Mad Money
$42.900
No
UnlockRating
DON'T BUY

Novavax Inc(NVAX-Q)

07/02/2022
Novavax Inc
The variability around earnings makes it interesting to trade, but he would not recommend investing in it. Very volatile. No insight for approval. Prefers using XPI ETF to trade the sector. NVAX is not a name he owns.
Pharma & Healthcare
Larry Berman CFA, CMT, CTA
$94.810
No
UnlockRating
DON'T BUY

Novavax Inc(NVAX-Q)

26/01/2022
Novavax Inc
The share price and PE have plunged in the past year. Though cheaper to buy, he passes, because they haven't gotten FDA approval for their Covid vaccine.
Pharma & Healthcare
Jim Cramer - Mad Money
$79.060
No
UnlockRating
DON'T BUY

Novavax Inc(NVAX-Q)

20/12/2021
Novavax Inc
Issued a Covid vaccines that the EU and WHO approved recently. He likes Pfizer in this group; you don't need another one. NVAX is up 6% in the past week.
Pharma & Healthcare
Jim Cramer - Mad Money
$202.000
No
UnlockRating
WEAK BUY

Novavax Inc(NVAX-Q)

07/12/2021
Novavax Inc
Eventually, a full, broad-spectrum vaccine will be in place to cover Covid. Will MRNA technology also develop drugs to tackle TV and HIV and other diseases. Novartis offers more a strong balance sheet and a just-announced $20 billion inflow, based on tuck-in acquisition. NVAX is fine, but there are better companies.
Pharma & Healthcare
Darren Sissons
$178.285
Unknown
UnlockRating
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

Novavax Inc(NVAX-Q)

05/10/2021
Novavax Inc
(A Top Pick Jul 21/21, Down 16.7%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with NVAX has triggered its stop at $175. To remain disciplined, we recommend covering the position at this time. Combined with the previous recommendation to cover half the position, this results in a net investment gain of 6%.
Pharma & Healthcare
The Panic-Proof Portfolio (Stockchase Research)
$170.000
Unknown
UnlockRating
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

Novavax Inc(NVAX-Q)

09/09/2021
Novavax Inc
(A Top Pick Jul 22/21, Up 29.4%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with NVAX has achieved its target at $272. To be disciplined, we recommend covering half the position at this time and trailing up the stop (from $160) to $175.
Pharma & Healthcare
The Panic-Proof Portfolio (Stockchase Research)
$258.850
Unknown
UnlockRating
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Novavax Inc(NVAX-Q)

22/07/2021
Novavax Inc
Stockchase Research Editor: Michael O'Reilly NVAX is applying for Emergency Use Authorization for its COVID-19 vaccine as experts believe annual boosters may be required as with the annual flu shots. It has achieved over 89% efficacy and does not require deep freeze storage -- a huge advantage. It has agreements already in place for 180 million doses in the UK, Canada, and Australia when approved. We would buy this with a stop loss at $160, looking to achieve $272 -- upside potential over 27%. Yield 0%. (Analysts’ price target is $271.75)
Pharma & Healthcare
The Panic-Proof Portfolio (Stockchase Research)
$210.180
Unknown
UnlockRating
DON'T BUY

Novavax Inc(NVAX-Q)

15/06/2021
Novavax Inc
Recently announced an effective Covid vaccine In 2019, they had less than $50 million in revenue. It was nascent and now prominent. They could participate in the booster Covid market, and they need to live up to their current market cap of $14 billion. NVAX has to vaccinate a quarter of the world's population to trade at 1x revenues. There's a lot of hope built into the shares that they succeed. He can't buy this and sleep at night.
Pharma & Healthcare
Gordon Reid
N/A
No
UnlockRating
DON'T BUY

Novavax Inc(NVAX-Q)

07/05/2021
Novavax Inc

It's not worth what it's selling for, and the stock should be lower. Moderna, in contrast, has more drugs in the pipeline, and he prefers this stock.

Pharma & Healthcare
Jim Cramer - Mad Money
$176.050
Unknown
UnlockRating
DON'T BUY

Novavax Inc(NVAX-Q)

18/03/2021
Novavax Inc

NVAX vs. PFE He'd absolutely go with PFE. Investors have been chasing growthy parts of the market and ignoring the stable areas. Vaccines don't move the needle for PFE the way they do for the others, but a great long-term investment if you think rates will stay lower. PFE is mature, decent balance sheet, good valuation.

Pharma & Healthcare
John Zechner
$219.540
Unknown
UnlockRating
DON'T BUY

Novavax Inc(NVAX-Q)

24/07/2020
Novavax Inc
There is almost an arms race that is going on with respect to vaccine development. We need to wait to see how human testing is going to work out. There will be lots of volatility in the meantime. He is not interested in playing a specific name -- much like what happened with marijuana stocks. He would look to companies that will provide syringes instead.
Pharma & Healthcare
Brett Girard, CPA, CA, CFA
$133.610
No
UnlockRating
Showing 1 to 12 of 12 entries
  • «
  • ‹
  • 1
  • ›
  • »

Novavax Inc(NVAX-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Novavax Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Novavax Inc(NVAX-Q) Frequently Asked Questions

What is Novavax Inc stock symbol?

Novavax Inc is a American stock, trading under the symbol NVAX-Q on the NASDAQ (NVAX). It is usually referred to as NASDAQ:NVAX or NVAX-Q

Is Novavax Inc a buy or a sell?

In the last year, there was no coverage of Novavax Inc published on Stockchase.

Is Novavax Inc a good investment or a top pick?

Novavax Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Novavax Inc.

Why is Novavax Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Novavax Inc worth watching?

0 stock analysts on Stockchase covered Novavax Inc In the last year. It is a trending stock that is worth watching.

What is Novavax Inc stock price?

On 2024-04-24, Novavax Inc (NVAX-Q) stock closed at a price of $4.15.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

CCI-NCrown Castle International
Crown Castle International
$95.44
-0.03 (-0.03%)
RTX-NRaytheon
Raytheon
$101.02
-0.36 (-0.36%)
FCX-NFreeport McMoran Copper & Gold
Freeport McMoran Copper & Gold
$48.24
0.25 (0.52%)
GEHC-QGE HealthCare Technologies Inc
GE HealthCare Technologies Inc
$86.67
0.42 (0.49%)
OTIS-NOtis Worldwide Corp.
Otis Worldwide Corp.
$93.37
-4.10 (-4.59%)
Advertising

Today's Top Picks

L-NLoews Corp
Loews Corp
$76.81
0.09 (0.12%)
KO-NCoca-Cola Company
Coca-Cola Company
$62.47
0.91 (1.44%)
QQQ-QInvesco QQQ Trust Series 1
Invesco QQQ Trust Series 1
$426.44
1.37 (0.32%)
AVGO-QBroadcom
Broadcom
$1,257.64
8.45 (0.67%)
MRVL-QMarvell Technology Group
Marvell Technology Group
$64.84
0.98 (1.49%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

NSC-NNorfolk Southern
Norfolk Southern
$236.22
-8.81 (-3.87%)
ALAB-QAstera Labs
Astera Labs
$70.92
-0.80 (-1.14%)
UNH-NUnitedHealth Group Inc
UnitedHealth Group Inc
$489.29
1.99 (0.41%)
AMD-QAdvanced Micro Devices
Advanced Micro Devices
$149.71
-2.03 (-1.37%)
NVDA-QNVIDIA Corporation
NVIDIA Corporation
$793.56
-3.21 (-0.41%)

Most Recent Experts

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Bolton

Kim Bolton

Black Swan Dexteritas

Stockchase

Stockchase Insights

5i Research

Cramer

Jim Cramer - Mad Money

CNBC

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.